Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

Anti-sclerostin monoclonal antibody shows promise in phase IIa hypophosphatasia trial

Nov. 4, 2013

Model used to predict increase in bone mineral density with DS-9194b

Nov. 4, 2013

Targeting siglec-15 with an antibody reduces bone loss in ovariectomized rats

Nov. 4, 2013

New data reported from extension study of Glassia in pediatric patients with type 1 diabetes

Oct. 31, 2013

ViaCyte granted over 20 patents in 2013

Oct. 31, 2013

Novel osteoporosis mouse models carry human RANKL gene

Oct. 30, 2013

Janssen Pharmaceutica divulges new CCR2 receptor antagonists

Oct. 30, 2013

BELLUS Health and AmorChem sign co-development agreement for AL amyloidosis

Oct. 30, 2013

Pfizer discloses new DGAT2 inhibitors

Oct. 28, 2013

Intranasal formulation of teriparatide may improve compliance

Oct. 28, 2013

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 10, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for April 7, 2026
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
MSD discloses new HCN1/2 blockers
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...
Orexin OX2 receptor agonists disclosed in Vertex Pharmaceuticals patent
BioWorld Science
Vertex Pharmaceuticals Inc. has patented new macrocyclic sulfonamide orexin OX2 receptor agonists potentially useful for the treatment of amyotrophic lateral...